Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Barbara Haeberlin, Munchenstein CH
Barbara Haeberlin, Munchenstein CH
| Patent application number | Description | Published |
|---|---|---|
| 20080274189 | Organic Compounds Comprising a Glycopyrr Onium Salt - Medicaments comprising (A) an antimuscarinic agent and (B) a corticosteroid for the treatment of inflammatory or obstructive airways diseases. | 11-06-2008 |
| 20080279948 | Treatment of Asthma and Copd Using Triple-Combination Therapy - A medicament comprising, separately or together (A) a compound of formula I | 11-13-2008 |
| 20080286363 | Pharmaceutical Compositions for the Treatment of Inflammatory and Obstructive Airways Diseases - A medicament comprising, separately or together (A) a compound of formula I | 11-20-2008 |
| 20080317862 | Organic Compounds Comprising a Glycopyrrolium Salt - Medicaments comprising (A) an antimuscarinic agent and (B) a corticosteroid for the treatment of inflammatory or obstructive airways diseases. | 12-25-2008 |
| 20100166671 | ORGANIC COMPOUNDS - Medicaments comprising (A) an antimuscarinic agent, (B) a beta-2 adrenoreceptor agonist and (C) a corticosteroid for the treatment of inflammatory or obstructive airways diseases. | 07-01-2010 |
| 20100215734 | PHARMACEUTICAL COMPOSITIONS - The present invention provides a pharmaceutical composition in solid form comprising a poorly water soluble drug, a solubilizing component, and a surfactant which is semisolid or solid. The poorly soluble drug may e.g. be a cyclosporin or a macrolide. | 08-26-2010 |
| 20100221331 | PHARMACEUTICAL COMPOSITIONS COMPRISING COLLOIDAL SILICON DIOXIDE - The present invention provides a pharmaceutical composition comprising a macrolide solid dispersion, a disintegrant and colloidal silicon dioxide. The composition comprises 1 to 5% colloidal silicon dioxide by weight. | 09-02-2010 |
| 20110306630 | PHARMACEUTICAL COMPOSITIONS COMPRISING COLLOIDAL SILICON DIOXIDE - A pharmaceutical composition comprising a macrolide solid dispersion, a disintegrant and colloidal silicon dioxide, wherein the composition comprises 1 to 5% colloidal silicon dioxide by weight. | 12-15-2011 |